Integrative genomic and single-cell framework identifies druggable targets for colorectal cancer precision therapy
BackgroundColorectal cancer (CRC) remains a leading cause of cancer-related mortality worldwide. Despite therapeutic advances, there is a critical need to identify novel, effective, and safe drug targets to improve precision treatment strategies.MethodsWe developed a multi-layered framework integrat...
Saved in:
| Main Authors: | Yanggang Hong, Jiajun Li, Nuo Xu, Wanyi Shu, Feng Chen, Yuze Mi, Haigang Geng, Qian Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1604154/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis
by: Ioannis Parodis, et al.
Published: (2024-06-01) -
Identification of druggable genes for schizophrenia based on Mendelian randomization
by: LIAN Kun, et al.
Published: (2025-02-01) -
Mapping chromatin remodelling in glioblastoma identifies epigenetic regulation of key molecular pathways and novel druggable targets
by: Claire Vinel, et al.
Published: (2025-02-01) -
Identifying therapeutic target genes for diabetic retinopathy using systematic druggable genome-wide Mendelian randomization
by: Long Xie, et al.
Published: (2025-04-01) -
Identifying potential drug targets for tourette syndrome: a Mendelian randomization study based on druggable genes
by: Shilin Zhou, et al.
Published: (2025-06-01)